Key Financial Data Of Group

Carna Biosciences, Inc. - Filing #7272198

Concept As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
Key financial data of group
Business results of group
Net sales
542,056,000 JPY
636,235,000 JPY
1,625,889,000 JPY
1,468,204,000 JPY
1,386,748,000 JPY
1,216,066,000 JPY
1,931,718,000 JPY
2,017,529,000 JPY
1,133,346,000 JPY
1,042,960,000 JPY
Ordinary profit (loss)
-2,072,150,000 JPY
-2,080,739,000 JPY
-1,126,283,000 JPY
-1,176,623,000 JPY
-1,278,820,000 JPY
-1,357,020,000 JPY
-548,843,000 JPY
-522,992,000 JPY
-1,077,096,000 JPY
-1,096,348,000 JPY
Profit (loss) attributable to owners of parent
-2,178,576,000 JPY
-1,152,895,000 JPY
-1,349,539,000 JPY
-534,474,000 JPY
-1,111,032,000 JPY
Comprehensive income
-2,144,646,000 JPY
-1,135,377,000 JPY
-1,331,861,000 JPY
-510,976,000 JPY
-1,119,890,000 JPY
Net assets
2,198,126,000 JPY
2,475,354,000 JPY
3,877,535,000 JPY
3,624,863,000 JPY
3,641,844,000 JPY
3,439,714,000 JPY
4,194,643,000 JPY
4,315,572,000 JPY
3,741,428,000 JPY
3,824,010,000 JPY
Total assets
2,491,642,000 JPY
2,772,115,000 JPY
4,349,891,000 JPY
4,086,919,000 JPY
4,266,453,000 JPY
4,046,289,000 JPY
5,305,486,000 JPY
5,432,560,000 JPY
4,748,867,000 JPY
4,835,356,000 JPY
Net assets per share
115.11
129.62
226.16
211.43
255.04
240.82
314.45
323.54
301.39
308.05
Basic earnings (loss) per share
-121.08
-121.64
-68.62
-70.53
-99.10
-103.20
-43.83
-42.10
-90.33
-91.84
Diluted earnings per share
Equity-to-asset ratio
0.882 xbrli:pure
0.893 xbrli:pure
0.891 xbrli:pure
0.887 xbrli:pure
0.850 xbrli:pure
0.846 xbrli:pure
0.789 xbrli:pure
0.793 xbrli:pure
0.787 xbrli:pure
0.790 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-1,374,806,000 JPY
-1,677,464,000 JPY
-708,390,000 JPY
-1,536,612,000 JPY
-1,260,972,000 JPY
Net cash provided by (used in) investing activities
-13,060,000 JPY
-11,376,000 JPY
-125,696,000 JPY
-41,677,000 JPY
-70,433,000 JPY
Net cash provided by (used in) financing activities
567,441,000 JPY
1,182,027,000 JPY
367,006,000 JPY
1,064,987,000 JPY
724,423,000 JPY
Cash and cash equivalents
2,108,484,000 JPY
2,889,101,000 JPY
3,379,048,000 JPY
3,817,834,000 JPY
4,299,142,000 JPY
Number of employees
7 xbrli:pure
60 xbrli:pure
33 xbrli:pure
34 xbrli:pure
20 xbrli:pure
22 xbrli:pure
7 xbrli:pure
63 xbrli:pure
67 xbrli:pure
64 xbrli:pure
65 xbrli:pure
62 xbrli:pure
61 xbrli:pure
64 xbrli:pure
61 xbrli:pure
64 xbrli:pure
Average number of temporary employees
2 xbrli:pure
10 xbrli:pure
4 xbrli:pure
4 xbrli:pure
4 xbrli:pure
4 xbrli:pure
2 xbrli:pure
10 xbrli:pure
8 xbrli:pure
8 xbrli:pure
8 xbrli:pure
8 xbrli:pure
9 xbrli:pure
9 xbrli:pure
4 xbrli:pure
4 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.